Taiwan's Orient Europharma Negotiates Opening In Middle East, Africa Markets
This article was originally published in PharmAsia News
Executive Summary
Taiwan-based Orient Europharma announced an agreement to transfer production technology to Cooper Pharma of Morocco
Taiwan-based Orient Europharma announced an agreement to transfer production technology to Cooper Pharma of Morocco. Drugs for the treatment of sleeping disorders and diabetes are to be transferred to Cooper Pharma, which is to market them in Morocco, French-speaking areas in West Africa and in Saudi Arabia. Officials of Orient Europharma said the deal gives their firm an opening in the Middle Eastern and African markets, which are expected to grow at an annual rate of 11 percent. (Click here for more) "Drug Maker To Transfer Technology To Morocco Firm" - Focus Taiwan (9/24/10) |